Epigenomics AG

If you scan the landscape of colorectal cancer screening tests in the US, you will find companies positioning their blood-based screening tests on various perches – some waiting for imminent launches,

Detecting and treating cancer before it invades or metastasizes is the best way to ensure the patient survives the disease. Yet, cancers can be asymptomatic for so long that early detection can be dif

Company Changes BERTOLINO , Arthur P., MD, PhD To: Cellceutix Corp. , Pres. & CMO (June) From: Innovation Dermatologics Inc., CEO Phone: 978-236-8717 COLOMA , Jason V., PhD To: Corvus Pharm

Merger and acquisition activity in the Chinese healthcare sector has ramped up in recent months, highlighted by several large cross-border deals in the blood products sector. On April 7, China’s Creat